Vartika Bisht

TL;DR: The clinical and demographic characteristics and COVID-19 outcomes in patients with cancer appear to be principally driven by age, gender, and comorbidities.

TL;DR: This study compared adult patients with cancer enrolled in the UK Coronavirus Cancer Monitoring Project between March 18 and May 8, 2020 with a parallel non-COVID-19 UK cancer control population, and analyzed the effect of primary tumour subtype, age, and sex and on severe acute respiratory syndrome coronavirus 2 prevalence and the case–fatality rate during hospital admission.

TL;DR: The past, present and future of clinical biomarker development is discussed, including the identification of physicochemical assays, current regulations, the development and reproducibility of clinical trials, as well as the revolution of omics technologies and state-of-the-art integration and analysis approaches.

TL;DR: In this article, the authors used public omics data sets to investigate potential associations between microbiome, metabolome, bulk transcriptomics and single cell RNA sequencing datasets, and identified multiple potential interactions, for example 5aminovalerate interacting with Adlercreutzia; cholesteryl ester interacting with bacterial genera Staphylococcus, Blautia and Roseburia.

TL;DR: Bisht et al. as mentioned in this paper developed a multimodal framework that considers sparsity (excessive zeros), lower effect size, intrinsically microbial correlations, as well as background biomedical knowledge in the form of a cluster-infused enriched network architecture.